ES2032276T3 - Metodo para el tratamiento de plasma y productos derivados del mismo. - Google Patents

Metodo para el tratamiento de plasma y productos derivados del mismo.

Info

Publication number
ES2032276T3
ES2032276T3 ES198787101072T ES87101072T ES2032276T3 ES 2032276 T3 ES2032276 T3 ES 2032276T3 ES 198787101072 T ES198787101072 T ES 198787101072T ES 87101072 T ES87101072 T ES 87101072T ES 2032276 T3 ES2032276 T3 ES 2032276T3
Authority
ES
Spain
Prior art keywords
plasma
blood
treatment
same
products derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787101072T
Other languages
English (en)
Inventor
Harold C. Mielke
Patrick J. Scannon
Paul R. Sohmer
John C. Klock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of ES2032276T3 publication Critical patent/ES2032276T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UN METODO PARA TRATAR PLASMA SANGUINEO HUMANO QUE COMPRENDE, PASAR EL PLASMA A TRAVES DE UNA ZONA INMUNOABSERBENTE CAPAZ DE LIGAR AMBOS GRUPOS ANTICUERPOS SANGUINEOS ANTI - A Y ANTI - B Y ELIMINARLOS DEL PLASMA. EL PLASMA PARA SER TRASPASADO A UN RECIPIENTE CONSIDERADO DEL TIPO DE SANGRE DEL RECIPIENTE Y ES ENCONTRADO TAL QUE EL PLASMA TRATADO RETIENE SUSTANCIALMENTE TODAS LAS OTRAS PROTEINAS SANGUINEAS ESENCIALES PARA LA PROPIA ACTIVIDAD FISIOLOGICA.
ES198787101072T 1984-07-19 1987-01-27 Metodo para el tratamiento de plasma y productos derivados del mismo. Expired - Lifetime ES2032276T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/632,756 US4664913A (en) 1982-05-24 1984-07-19 Method for treating plasma for transfusion

Publications (1)

Publication Number Publication Date
ES2032276T3 true ES2032276T3 (es) 1993-02-01

Family

ID=24536816

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787101072T Expired - Lifetime ES2032276T3 (es) 1984-07-19 1987-01-27 Metodo para el tratamiento de plasma y productos derivados del mismo.

Country Status (7)

Country Link
US (1) US4664913A (es)
EP (1) EP0276342B1 (es)
AT (1) ATE74282T1 (es)
AU (1) AU596392B2 (es)
DE (1) DE3778002D1 (es)
ES (1) ES2032276T3 (es)
GR (1) GR3004763T3 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US6620382B1 (en) 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
WO2001027623A2 (en) * 1999-10-08 2001-04-19 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
EP1420641A4 (en) * 2001-08-01 2005-05-25 Anil K Chauhan IMMUNE COMPLEX
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
RU2362571C2 (ru) * 2003-12-19 2009-07-27 Октафарма Аг Вирус-инактивированная плазма крови универсального применения, полученная из порций плазмы индивидуумов, не относящихся к европеоидной расе
WO2005107802A2 (en) * 2004-04-30 2005-11-17 Biopheresis Technologies, Llc Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US8449520B2 (en) * 2007-03-19 2013-05-28 HemCon Medical Technologies Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US7776022B2 (en) * 2007-03-19 2010-08-17 Hemcon Medical Technologies Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10793327B2 (en) 2017-10-09 2020-10-06 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
EP3938742A1 (en) 2019-03-14 2022-01-19 Terumo BCT Biotechnologies, LLC Multi-part lyophilization container and method of use
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533440A1 (fr) * 1982-09-24 1984-03-30 Inst Nat Sante Rech Med Dispositif pour l'elimination ou la recuperation de substances biologiquement actives a partir du sang, son obtention et son utilisation
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens

Also Published As

Publication number Publication date
EP0276342A1 (en) 1988-08-03
US4664913B1 (es) 1990-01-30
AU596392B2 (en) 1990-05-03
EP0276342B1 (en) 1992-04-01
AU6804987A (en) 1988-08-04
US4664913A (en) 1987-05-12
ATE74282T1 (de) 1992-04-15
DE3778002D1 (de) 1992-05-07
GR3004763T3 (es) 1993-04-28

Similar Documents

Publication Publication Date Title
ES2032276T3 (es) Metodo para el tratamiento de plasma y productos derivados del mismo.
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
NO166943C (no) Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider.
EP0199479A3 (en) Ozone decontamination of blood and blood products
DE3482405D1 (de) Saugfaehiges wergwerferzeugnis mit vereinigten wirkstoffen zur behandlung und prophylaxe von windelausschlag und windeldermatitis.
ATE193418T1 (de) Dekontaminierung von plättchen mit 8- methoxypsoralen
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3381624D1 (de) Mittel zur behandlung von wunden.
DK137589D0 (da) Salicylsyreholdigt middel til behandling af hudsygdomme
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
ES530592A0 (es) Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ES2059826T3 (es) Utilizacion de quimotripsina para inactivar el activador de precalicreina en productos sanguineos derivados de plasma humano o animal.
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
GR75239B (es)
JPS51121530A (en) Toiletries
BR8107002A (pt) Composicao de diester para tratamento textil fibra sintetica revestida e conversao tratamento e processos de preparacao
JPS51142514A (en) Materials for beauty culture and medicine consisting of the juice of n atural vegetables and fruits
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
DE69433851D1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 276342

Country of ref document: ES